Dr. Melissa Kaye, MD

Dr. Kaye practices at Presbyterian Medical Group in Albuquerque, New Mexico.

Dr. Kaye's NPI, 1760547251, was assigned on December 26, 2006. Dr. Kaye graduated from MCP-Hahnemann College of Medicine in 1992. Dr. Kaye holds New Mexico license MD2022-0163.

Dr. Kaye's primary practice is Presbyterian Medical Group, at 1325 Wyoming NE Blvd, Albuquerque, NM 87112 in Bernalillo County. The practice phone is (505) 823-8556.

Dr. Kaye's primary practice is Presbyterian Medical Group in Albuquerque, New Mexico. Dr. Kaye is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Kaye to 4 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaye practices, 7 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Kaye's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Kaye is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kaye's licenses on file in 6 states: New Mexico, New York, Georgia, Illinois, Missouri and Ohio.

CMS data shows 151 Medicare services from Dr. Kaye across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $15,053 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Dr. Kaye in 2024. The largest group is under 65, with 37 patients. 71% of them have anxiety, and 63% have high cholesterol. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaye's median patient age at 40, with 61% women.

In 2024, Dr. Kaye wrote 860 Medicare Part D claims for 75 patients. 96% of them were for generic drugs. CMS names the drug for 711 of them, across 28 drugs with 11 or more claims each, at $15,676 in total drug cost. In 2021, CMS named 984 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kaye for performance year 2024, reported as part of a group. Dr. Kaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaye as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Kaye from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $96.

Dr. Kaye graduated from MCP-Hahnemann College of Medicine in 1992.

Dr. Kaye is in network with 10 carriers, including Elevance, HCSC and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.